Did Hedge Funds Make The Right Call On Perrigo Company (PRGO) ?
Insider Monkey · 1天前
Perrigo: Bloodied But Unbowed - Stock Can Rise Further Than It Can Fall
Seeking Alpha - Article · 06/29 16:19
Sol-Gel inks deal for three new generic product candidates with Perrigo
Seeking Alpha - Article · 06/29 12:38
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
Sol-Gel Technologies, Ltd. (SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that it has entered into collaborative
GlobeNewswire · 06/29 11:00
The Week In Cannabis: Mixed Stock Performance Driven By Mixed Bag Of News
Benzinga · 06/21 20:32
The Week In Cannabis: Mixed Stock Performance Driven By Mixed Bag Of News
A week with mixed performance among cannabis stocks came with a wide array of news.
Benzinga · 06/21 19:32
Perrigo Announces The Closing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company
PR Newswire · 06/19 19:03
Perrigo (PRGO) Presents At Oppenheimer Consumer Growth and E-Commerce Conference - Slideshow
Perrigo Company plc（简称Perrigo，原名：Perrigo Company Limited）是一家非处方（OTC）消费品与特种药品公司。该公司的业务部门包括消费者保健（CHC）、品牌消费者保健（BCH）、处方药（Rx）、专业科学和其他。该公司生产OTC保健用品，并向商店自有品牌市场提供婴儿配方奶粉。该公司还是通用扩展处方产品的提供商。CHC部门主要销售OTC商店自有品牌产品。BCH部门开发、制造、营销和分销多种欧洲品牌OTC。Rx部门负责开发、制造和销售一系列通用与特种药物处方药。专业科学部门包括治疗多发性硬化的资产，特别是与药物Tysabri有关的资产。其他部门主要包括活性药物成分（API）业务。